{"derived":{"adj":{"INE0JWS01":[]},"dividends_by_fy":{"INE0JWS01":{}}},"events":[{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"543998","class":"equity","confidence":1.0,"detail":"1:4 at Rs 75","event_id":"INE0JWS01:2025-07-18:rights:0","ex":"2025-07-18","ex_move":{"move":-11.77,"on":["2025-07-18",102.79],"pre":["2025-07-17",116.5]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"rights_den":"nse_pr_bc","rights_num":"nse_pr_bc","rights_premium":"nse_pr_bc","rights_price":"nse_pr_bc"},"fields":{"rights_den":4,"rights_num":1,"rights_premium":65.0,"rights_price":75.0},"flags":["code_inferred"],"group":"equity","instrument_id":"INE0JWS01017","isin_after":null,"isin_at_event":"INE0JWS01017","issuer_id":"INE0JWS","lineage":"INE0JWS01","name":"Valiant Laboratories Limited","nd_from":"2025-07-18","nd_to":"2025-07-18","payment":null,"price_adjust":true,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2025-07-16","last_seen":"2025-07-18","purpose":"RIGHTS 1:4 @ PRM RS 65/-","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"VALIANTLAB"},{"ex_from_record":false,"first_seen":"2025-07-16","last_seen":"2025-07-18","purpose":"RIGHTS 1:4 @ PRM RS 65/-","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"VALIANTLAB"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Rights 1:4 @ Premium Rs 65/-","scrip":null,"series":"EQ","src":"nse_api","symbol":"VALIANTLAB"},{"ex_from_record":false,"first_seen":"2026-10-04","last_seen":"2026-10-04","purpose":"Right Issue of Equity Shares","scrip":"543998","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-09-11","last_seen":"2026-11-12","purpose":"ET-00010004","scrip":"543998","series":null,"src":"bse_corpact","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"VALIANTLAB","purpose":"Rights Issue in the ratio of 1:4","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":"2025-07-19","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","bse_corpact","mse_ca"],"subtype":null,"symbol":"VALIANTLAB","type":"rights"},{"announce":"2026-10-27","bc_from":null,"bc_to":null,"bse_scrip":"543998","class":"equity","confidence":1.0,"detail":"Financial results for the period ended Sep 2026","event_id":"INE0JWS01:2026-11-02:meeting:0","ex":"2026-11-02","exchanges":["BSE","NSE"],"field_provenance":{"agenda":"nse_bm","attachment":"nse_bm","period":"nse_bm"},"fields":{"agenda":["results"],"attachment":"https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_22072_WebXMLFile_20261027_172953284.xml","period":"2026-09"},"flags":[],"group":"equity","instrument_id":"INE0JWS01017","isin_after":null,"isin_at_event":"INE0JWS01017","issuer_id":"INE0JWS","lineage":"INE0JWS01","name":"Valiant Laboratories Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2026-10-27","last_seen":"2026-11-12","purpose":"BOARD MEETING: Board Meeting Intimation | Valiant Laboratories Limited has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Quarterly ended September 2026 .","scrip":null,"series":"EQ","src":"nse_bm","symbol":"VALIANTLAB"},{"ex_from_record":false,"first_seen":"2026-10-27","last_seen":"2026-11-12","purpose":"BOARD MEETING: Financial Results | To consider and approve the financial results for the period ended September 30, 2026","scrip":null,"series":"EQ","src":"nse_bm","symbol":"VALIANTLAB"},{"ex_from_record":false,"first_seen":"2026-10-28","last_seen":"2026-11-12","purpose":"BOARD MEETING: Quarterly Results","scrip":"543998","series":null,"src":"bse_bm","symbol":null}],"record":null,"series":"EQ","sources":["nse_bm","bse_bm"],"subtype":"board","symbol":"VALIANTLAB","type":"meeting"}],"instruments":[{"bse":["543998"],"class":"equity","coupon_pct":null,"coupon_src":null,"frequency":null,"isin":"INE0JWS01017","last_event":"2026-11-02","maturity":null,"n_events":2,"name":"Valiant Laboratories Limited","next_event":null,"nse":["VALIANTLAB"],"status":"listed","symbol":"VALIANTLAB","ticker":"VALIANTLAB"},{"bse":["751016"],"class":"rights_entitlement","coupon_pct":null,"coupon_src":null,"frequency":null,"isin":"INE0JWS20017","last_event":null,"maturity":null,"n_events":0,"name":"VALIANT LABORATORIES LTD","next_event":null,"nse":["VALIANT-RE"],"status":"suspended","symbol":"VALIANT-RE","ticker":"VALIANT-RE"}],"issuer":{"bse_scrips":["543998","751016"],"bse_tickers":["VALIANTLAB","VALIANT-RE"],"classes":{"equity":1,"rights_entitlement":1},"delisted_on":null,"equity_isins":["INE0JWS01017"],"file":"INE0JWS","first_year":"2025","industry":"Pharmaceuticals & Biotechnology","issuer_id":"INE0JWS","last_seen":"2026-11-12","last_year":"2026","mse_listed":false,"mse_symbols":["VALIANTLAB"],"n_events":2,"n_instruments":2,"name":"Valiant Laboratories Limited","names":["VALIANT LABORATORIES LTD","Valiant Laboratories Limited"],"next_ex":null,"nse_symbols":["VALIANT-RE","VALIANTLAB"],"px":true,"sector":"Healthcare","slug":"VALIANTLAB","status":"listed"}}